Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Equasym XL versus placebo crossover trial on academic activity in children with ADHD
NL-OMON37537Phase 4Active, not recruiting
- Sponsor
- Vrije Universiteit Amsterdam
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (3 arms), sponsored by Vrije Universiteit Amsterdam. Primary endpoints: Academic productivity, Academic ability and 3 more. Started Jan 2013; status: active, not recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NL-OMON37537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37537.